Compared to sitagliptin, liraglutide was also found to increase VEGF, which is a mediator of angiogenesis and might attenuate the adverse consequences of large vessel atherosclerosis by inducing the formation of collateral vessels in obese type 2 diabetic patients [8]. Here, VEGFA is linked to atherosclerosis.